Posts Tagged: NYSE: ZYME
Zymeworks Inc (NYSE: ZYME), a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics, stock rose 8.76% on September 14th, 2020 (Source: Google…
Zymeworks Inc (NYSE: ZYME) stock rose 11.36% on Jan 20th, 2020 (Source: Google finance) and continued its bullish momentum by rising by over 1 %…
Zymeworks Inc (NYSE: ZYME) stock has risen over 227% in 2019 (Source: Finviz.com). The company updated Phase 1 data for single agent ZW25 in heavily…